PHAXIAM Therapeutics SA (PHXM) Free Cash Flow

Annual FCF

-$33.59 M
+$33.93 M+50.26%

December 31, 2022

Summary

Performance

1-Year Change

+50.26%

3-Year Change

+52.71%

5-Year Change

-12.38%

15-Year Change

-12.38%

PHXM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$731.40 K
PHXM annual free cash flow is currently -4692.26% below its historical high of $731.40 thousand

3-Year Low

-$67.52 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PHXM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PHXM next annual earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Annual CFO

-$33.50 M
PHXM annual cash flow from operations is -$33.50 million

Annual CFF

-$1.86 M
PHXM annual cash flow from financing activities is -$1.86 million

Annual CFI

$40.21 M
PHXM annual cash flow from investing activities is $40.21 million

Annual CAPEX

-
PHXM annual capital expenditures value is unknown

Quarterly FCF

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$22.05 M
PHXM quarterly free cash flow is currently at an all-time high

3-Year Low

-$22.05 M
PHXM quarterly free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Quarterly CFO

-
PHXM quarterly cash flow from operations value is unknown

Quarterly CFF

-
PHXM quarterly cash flow from financing activities value is unknown

Quarterly CFI

-
PHXM quarterly cash flow from investing activities value is unknown

Quarterly CAPEX

-
PHXM quarterly capital expenditures value is unknown

TTM FCF

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$22.05 M
PHXM TTM free cash flow is currently at an all-time high

3-Year Low

-$22.05 M
PHXM TTM free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

TTM CFO

-
PHXM TTM cash flow from operations value is unknown

TTM CFF

-
PHXM TTM cash flow from financing activities value is unknown

TTM CFI

-
PHXM TTM cash flow from investing activities value is unknown

TTM CAPEX

-
PHXM TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$33.59 M
PHXM annual free cash flow is -$33.59 million

Annual CFO

-$33.50 M
PHXM annual cash flow from operations is -$33.50 million

Annual CAPEX

-
PHXM annual capital expenditures value is unknown

PHXM Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+50.3%--
3 y3 years+52.7%--
5 y5 years-12.4%--

PHXM Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+101.0%
5 y5-yearat high+111.5%
alltimeall time-4692.3%+111.5%

PHAXIAM Therapeutics SA Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2022
-$33.59 M(-50.3%)
-
-
Jun 2022
-
-$22.05 M(-44.1%)
-$22.05 M(-44.1%)
Dec 2021
-$67.52 M(+11.8%)
-
-
Jun 2021
-
-$39.48 M(+18.7%)
-$39.48 M(-58.8%)
Dec 2020
-$60.37 M(-15.0%)
-
-
Jun 2020
-
-$33.27 M(-46.8%)
-$95.83 M(-12.2%)
Dec 2019
-$71.02 M
-
-
Sep 2019
-
-$62.57 M(+34.3%)
-$109.15 M(+16.5%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$46.59 M(-1.1%)
-$93.71 M(+98.9%)
Dec 2018
-$63.17 M(+111.3%)
-
-
Sep 2018
-
-$47.12 M
-$47.12 M
Dec 2017
-$29.89 M(+39.5%)
-
-
Dec 2016
-$21.43 M(+30.1%)
-
-
Dec 2015
-$16.48 M(+61.6%)
-
-
Dec 2014
-$10.20 M(+11.3%)
-
-
Dec 2013
-$9.16 M(-1353.0%)
-
-
Dec 2012
$731.40 K
-
-

FAQ

  • What is PHAXIAM Therapeutics SA annual free cash flow?
  • What is the all time high annual FCF for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA annual FCF year-on-year change?
  • What is the all time high quarterly FCF for PHAXIAM Therapeutics SA?
  • What is the all time high TTM FCF for PHAXIAM Therapeutics SA?

What is PHAXIAM Therapeutics SA annual free cash flow?

The current annual FCF of PHXM is -$33.59 M

What is the all time high annual FCF for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high annual free cash flow is $731.40 K

What is PHAXIAM Therapeutics SA annual FCF year-on-year change?

Over the past year, PHXM annual free cash flow has changed by +$33.93 M (+50.26%)

What is the all time high quarterly FCF for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high quarterly free cash flow is -$22.05 M

What is the all time high TTM FCF for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high TTM free cash flow is -$22.05 M